Terms: = Cervical cancer AND ELN, ENSG00000049540, 2006, WS, WBS, SVAS, FLJ43523, FLJ38671
1652 results:
1. Effect of the HPV vaccination programme on incidence of cervical cancer and grade 3 cervical intraepithelial neoplasia by socioeconomic deprivation in England: population based observational study.
Falcaro M; Soldan K; Ndlela B; Sasieni P
BMJ; 2024 May; 385():e077341. PubMed ID: 38749552
[TBL] [Abstract] [Full Text] [Related]
2. Clinical Significance of Serum SCC Levels Before Treatment for Locally Advanced cervical Squamous Cell Carcinoma.
Yamaoka Y; Tamura S; Yamanoi K; Taki M; Murakami R; Yamaguchi K; Hamanishi J; Mandai M
Anticancer Res; 2024 May; 44(5):2009-2019. PubMed ID: 38677756
[TBL] [Abstract] [Full Text] [Related]
3. Impact of weighting on the association between sociodemographic characteristics, health behaviours and cancer, cardiovascular and all-cause mortality in the Australian 45 and Up Study.
Yap S; Luo Q; Wade S; Ngo P; Goldsbury D; Sarich P; Banks E; Weber M; Canfell K; David M; Steinberg J
Cancer Epidemiol; 2024 Jun; 90():102567. PubMed ID: 38603997
[TBL] [Abstract] [Full Text] [Related]
4. Evaluation and Prediction Analysis of 3- and 5-Year Relative Survival Rates of Patients with cervical cancer: A Model-Based Period Analysis.
Fan X; He W; Zhang Q; Zhang B; Dong L; Li L; Liu X
Cancer Control; 2024; 31():10732748241232324. PubMed ID: 38408865
[TBL] [Abstract] [Full Text] [Related]
5. Prevalence of genital high-risk human papillomavirus infections and associated factors among women living with human immunodeficiency virus in Uganda.
Nakigozi H; Ndejjo R; Bazeyo W; Nabaggala A; Achola C; Iga M; Kalyesubula S; Kanamwangi B; Mutungi G; Batte C; Mukunya D; Sserwanga L; Gemageine G; Oyoo CA; Nabadda S
BMC Cancer; 2024 Feb; 24(1):243. PubMed ID: 38383366
[TBL] [Abstract] [Full Text] [Related]
6. High impact of quadrivalent human papillomavirus vaccine across racial/ethnic groups: National Health and Nutrition Examination Survey, 2003-2006 and 2015-2018.
Stefanos R; Lewis RM; Querec TD; Gargano JW; Unger ER; Markowitz LE
Hum Vaccin Immunother; 2024 Dec; 20(1):2308378. PubMed ID: 38372273
[TBL] [Abstract] [Full Text] [Related]
7. Late endocrine diseases in survivors of adolescent and young adult cancer in California: a population-based study.
Abrahão R; Brunson A; Ruddy KJ; Li Q; Li J; Ryder MM; Chubak J; Nichols HB; Sauder CAM; Gray MF; Hahn EE; Wun T; Keegan THM
Br J Cancer; 2024 Apr; 130(7):1166-1175. PubMed ID: 38332179
[TBL] [Abstract] [Full Text] [Related]
8. The value of the first postoperative diagnostic I-131 scan in patients with papillary thyroid carcinoma.
Ran B; Shang J; Chen Y; Zhou M; Li H; He W; Li Y; Cai Q; Guo B; Gong J; Xu H
J Cancer Res Clin Oncol; 2024 Feb; 150(2):80. PubMed ID: 38319395
[TBL] [Abstract] [Full Text] [Related]
9. Serum squamous cell carcinoma antigen level and magnetic resonance imaging for the prognosis of locally advanced cervical cancer.
Gu LN; Yu JW; Jiang L; Liu TB; Xu Y
Eur Rev Med Pharmacol Sci; 2024 Jan; 28(2):668-678. PubMed ID: 38305609
[TBL] [Abstract] [Full Text] [Related]
10. Late venous thromboembolism in survivors of adolescent and young adult cancer: A population-based study in California.
Abrahão R; Brunson A; Chubak J; Wernli KJ; Nichols HB; Chao C; Ruddy KJ; Hahn EE; Li Q; Malogolowkin MH; Sauder CAM; Kushi LH; Wun T; Keegan THM
Thromb Res; 2024 Mar; 235():1-7. PubMed ID: 38244373
[TBL] [Abstract] [Full Text] [Related]
11. Prognostic model for survival in patients with neuroendocrine carcinomas of the cervix: SEER database analysis and a single-center retrospective study.
Yu C; Wu X; Zhang S; Zhang L; Zhang H; Yang H; Zhao M; Li Z
PLoS One; 2024; 19(1):e0296446. PubMed ID: 38181016
[TBL] [Abstract] [Full Text] [Related]
12. Factors influencing HPV vaccine implementation in South Asia: a scoping review protocol.
Rajkhowa P; Pundir P; Dsouza SM; Patil DS; Narayanan P; Brand H
Syst Rev; 2024 Jan; 13(1):14. PubMed ID: 38178265
[TBL] [Abstract] [Full Text] [Related]
13. Perspectives of HPV vaccination among young adults: a qualitative systematic review and evidence synthesis protocol.
Mantina NM; Nakayima Miiro F; Smith J; McClelland DJ; Magrath PA; Madhivanan P
BMJ Open; 2023 Dec; 13(12):e076234. PubMed ID: 38072486
[TBL] [Abstract] [Full Text] [Related]
14. Clinical Implications of Adding SPECT/CT to Radioiodine Whole-Body Scan in Patients With Differentiated Thyroid cancer: A Systematic Review and Meta-analysis.
Chong A; Seo Y; Bang JI; Park S; Kim K; Hong CM; Choi M; Oh SW; Lee SW
Clin Nucl Med; 2024 Mar; 49(3):215-225. PubMed ID: 38048517
[TBL] [Abstract] [Full Text] [Related]
15. Updated Trends in cervical cancer Brachytherapy Utilization and Disparities in the United States From 2004 to 2020.
Colson-Fearon D; Han K; Roumeliotis MB; Viswanathan AN
Int J Radiat Oncol Biol Phys; 2024 May; 119(1):154-162. PubMed ID: 38040060
[TBL] [Abstract] [Full Text] [Related]
16. Expression and gene regulatory network of S100A16 protein in cervical cancer cells based on data mining.
Zhang H; Yang Y; Xing W; Li Y; Zhang S
BMC Cancer; 2023 Nov; 23(1):1124. PubMed ID: 37978469
[TBL] [Abstract] [Full Text] [Related]
17. HPV testing in Polish population-based cervical cancer screening programme (HIPPO project)-study protocol of a randomised healthcare policy trial.
Glinska P; Komerska K; Janik B; Olkowicz J; Jedrzejewska I; Macios A; Wieszczy P; Kaminski MF; Arbyn M; Nowakowski A
BMC Cancer; 2023 Nov; 23(1):1118. PubMed ID: 37978452
[TBL] [Abstract] [Full Text] [Related]
18. The cervical cancer Treatment Gap in Mexico Under
McClellan SP; Unger-Saldaña K; Espinosa-Tamez P; Suazo-Zepeda E; Potter MB; Barquet-Muñoz SA; Torres-Ibarra L; Lamadrid-Figueroa H; Lajous M
Health Syst Reform; 2023 Dec; 9(1):2272371. PubMed ID: 37944505
[TBL] [Abstract] [Full Text] [Related]
19. A predictive model for patients with local-regionally advanced oropharyngeal squamous cell carcinoma treated after cervical lymph node dissection.
Xie X; Kang M; Qu Z; Gu K
J Cancer Res Clin Oncol; 2023 Dec; 149(19):17241-17251. PubMed ID: 37804427
[TBL] [Abstract] [Full Text] [Related]
20. Training health care providers to administer VIA as a screening test for cervical cancer: a systematic review of essential training components.
Brevik TB; da Matta Calegari LR; Mosquera Metcalfe I; Laake P; Maza M; Basu P; Todd A; Carvalho AL
BMC Med Educ; 2023 Sep; 23(1):712. PubMed ID: 37770904
[TBL] [Abstract] [Full Text] [Related]
[Next]
